Literature DB >> 7260799

Surgical management of chronic occlusive disease of the aortic arch vessels and vertebral arteries.

R Maggisano, J L Provan.   

Abstract

Occlusive disease of the aortic arch vessels is relatively rare and often missed initially. Of 41 patients treated surgically for this condition over a 10-year period 38 had arteriosclerotic lesions, 2 had symptoms secondary to vasculitis (Takayasu's arteritis) and 1 had a radiation injury to a subclavian artery. In 22 cases the left subclavian artery was involved; the right subclavian and innominate arteries were the next most commonly affected. Only four vertebral stenoses were treated. Most patients presented with a combination of arm and hindbrain ischemia that was shown radiologically to be associated with a subclavian steal syndrome, but in some only isolated arm symptoms or severe vertigo alone was experienced. There was a difference in blood pressure between the arms of at least 20 mm Hg in 88% of the patients. The treatment for 28 patients was creation of a carotid-subclavian bypass, for 6 the placement of a bypass graft from the ascending aorta to the subclavian or carotid artery or both, for a 3 a subclavian endarterectomy and for 4 vertebral angioplasty. There were no operative deaths, and 90% of the grafts were patent 1 to 72 months later. however, only 30 (73%) of the patients were asymptomatic and 9 (22%) had improved.

Entities:  

Mesh:

Year:  1981        PMID: 7260799      PMCID: PMC1705412     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  15 in total

1.  THE SURGICAL TREATMENT OF THE SUBCLAVIAN STEAL SYNDROME.

Authors:  A V DUMANIAN; C J FRAHM; L R PASCALE; L L TEPLINSKY; D R SANTSCHI
Journal:  J Thorac Cardiovasc Surg       Date:  1965-07       Impact factor: 5.209

2.  The hemodynamics of the axillary-axillary bypass.

Authors:  D J Mozersky; R W Barnes; D S Sumner; G P Callaway; D E Strandness
Journal:  Surg Gynecol Obstet       Date:  1972-12

3.  Surgical treatment of occlusion of the innominate, common carotid, and subclavian arteries: a 10 year experience.

Authors:  E S Crawford; M E De Bakey; G C Morris; J F Howell
Journal:  Surgery       Date:  1969-01       Impact factor: 3.982

4.  Venous crossover bypass grafts for arterial insufficiency.

Authors:  W K Ehrenfeld; S M Levin; E J Wylie
Journal:  Ann Surg       Date:  1968-02       Impact factor: 12.969

5.  Axillary-axillary bypass for the "subclavian steal" syndrome.

Authors:  J H Jacobson; D J Mozersky; H A Mitty; M J Brothers
Journal:  Arch Surg       Date:  1973-01

6.  Femoral-axillary bypass for cerebral vascular insufficiency.

Authors:  G Sproul
Journal:  Arch Surg       Date:  1971-12

7.  Occlusive disease of the common carotid and subclavian arteries treated by carotid-subclavian bypass. Analysis of 125 cases.

Authors:  E B Diethrich; H E Garrett; J Ameriso; E S Crawford; M el-Bayar; M E De Bakey
Journal:  Am J Surg       Date:  1967-11       Impact factor: 2.565

8.  Carotid-subclavian bypass: a hemodynamic study.

Authors:  R S Lord; W K Ehrenfeld
Journal:  Surgery       Date:  1969-09       Impact factor: 3.982

9.  Subclavian-subclavian bypass for correction of the subclavian steal syndrome.

Authors:  J E Forestner; S K Ghosh; J J Bergan; J Conn
Journal:  Surgery       Date:  1972-01       Impact factor: 3.982

10.  The subclavian steal syndrome.

Authors:  D A Killen; J H Foster; W G Gobbel; S E Stephenson; H A Collins; F T Billings; H W Scott
Journal:  J Thorac Cardiovasc Surg       Date:  1966-04       Impact factor: 5.209

View more
  1 in total

1.  Combined Transradial and Transfemoral Approach With Ostial Vertebral Balloon Protection for the Treatment of Patients With Subclavian Steal Syndrome.

Authors:  Rami Fakih; Sudeepta Dandapat; Alan Mendez-Ruiz; Aldo A Mendez; Mudassir Farooqui; Cynthia Zevallos; Darko Quispe Orozco; David Hasan; James Rossen; Edgar A Samaniego; Colin Derdeyn; Santiago Ortega-Gutierrez
Journal:  Front Neurol       Date:  2020-10-22       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.